Mortality and length of hospital stay in patients with liver cirrhosis based on their MELD score
DOI:
https://doi.org/10.52764/jms.24.32.1.2Abstract
abstract
Background: Cirrhosis is a major global health problem, especially in Pakistan due to the relatively high prevalence of chronic viral hepatitis. Liver cirrhosis causes 1.2 million deaths yearly worldwide, ranking as the 14th leading cause of death in the world. The aim of this study is to find the frequency of mortality and length of hospital stay in patients with liver cirrhosis based on their MELD score at admission. We also aim to study for prognostication in cirrhotic patients.
Methodology: A Descriptive cross sectional study was conducted in Medical Department of Khyber Teaching Hospital Peshawar. Data was collected within 06 months’ time from 17/10/2019 to 17/4/2020. A total of 100 patients were observed. Strict exclusion criteria had followed to limit confounders in the study results. Investigations required for calculation of MELD score such as serum creatinine, bilirubin and INR was done from hospital laboratory. In addition to the baseline investigations such as ultrasound abdomen. MELD score was calculated according to the formula. Patient’s preformed (Annexure-I). Admitted patients were followed for study out come in hospital mortality and length of hospital stay for at least 30 days. All information were noted in the sdesigned proforma.
RESULTS: In this study 100 patients were analyzed among which mean age was 53 years with SD ± 7.11. 42% percent patients were male and 58% patients were female. In hospital mortality was observed in 8 (8%) patients while mean hospital stay was 7 days with standard devation ± 4.12 in patients presenting with liver cirrhosis.
CONCLUSION: Our study concluded that the frequency of in-hospital mortality was 8% and mean length of hospital stay was 7± 4.12 days in patients with liver cirrhosis.
Key Words: in-hospital mortality, mean length of hospital stay
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hamza Ali Khan, Nizam Ud Din, Saleem Iqbal, Ghulam Abbas, Muhammad Yousaf, Badar Mahmood Shah, Shah Umam
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
